These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33177865)

  • 1. Comparison of Skin Permeation and Putative Anti-Inflammatory Activity of Commercially Available Topical Products Containing Ibuprofen and Diclofenac.
    Pradal J
    J Pain Res; 2020; 13():2805-2814. PubMed ID: 33177865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical NSAIDs for acute local pain relief:
    Pennick G; Robinson-Miller A; Cush I
    Drug Dev Ind Pharm; 2021 Jun; 47(6):908-918. PubMed ID: 34109888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing Topical Products Specifically to Reduce Inflammatory Pain from Gout: Transdermal NSAID Delivery and Monosodium Urate Solubility.
    Hooper MW; He L
    J Pain Res; 2022; 15():1825-1835. PubMed ID: 35791391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same.
    Pradal J; Vallet CM; Frappin G; Bariguian F; Lombardi MS
    J Pain Res; 2019; 12():1149-1154. PubMed ID: 31114298
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
    Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
    Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Nonsteroidal Anti-Inflammatory Drugs: The Importance of Drug, Delivery, and Therapeutic Outcome.
    Barkin RL
    Am J Ther; 2015; 22(5):388-407. PubMed ID: 22367354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal Permeation and Skin Retention of Diclofenac and Etofenamate/Flufenamic Acid From Over-the-Counter Pain Relief Products.
    Kopečná M; Kováčik A; Novák P; Boncheva Bettex M; Vávrová K
    J Pharm Sci; 2021 Jun; 110(6):2517-2523. PubMed ID: 33508308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Controlled Heat Application on Topical Diclofenac Formulations Evaluated by In Vitro Permeation Tests (IVPT) Using Porcine and Human Skin.
    Thomas S; Shin SH; Hammell DC; Hassan HE; Stinchcomb AL
    Pharm Res; 2020 Feb; 37(3):49. PubMed ID: 32034502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical permeation characteristics of diclofenac sodium from NaCMC gels in comparison with conventional gel formulations.
    Mohammed FA
    Drug Dev Ind Pharm; 2001 Nov; 27(10):1083-97. PubMed ID: 11794811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between the concentrations of prostaglandins and the nonsteroidal antiinflammatory drugs indomethacin, diclofenac, and ibuprofen.
    Giagoudakis G; Markantonis SL
    Pharmacotherapy; 2005 Jan; 25(1):18-25. PubMed ID: 15767216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%).
    Kohan HG; Baker DM; Sani S; Bielecki-Wilken KA; Ramirez A
    Int J Pharm Compd; 2021; 25(2):146-155. PubMed ID: 33798114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogel increases diclofenac skin permeation and absorption.
    Haltner-Ukomadu E; Sacha M; Richter A; Hussein K
    Biopharm Drug Dispos; 2019 Jul; 40(7):217-224. PubMed ID: 31242332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
    Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
    Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro permeation and in vivo anti-inflammatory and analgesic properties of nanoscaled emulsions containing ibuprofen for topical delivery.
    Abdullah GZ; Abdulkarim MF; Salman IM; Ameer OZ; Yam MF; Mutee AF; Chitneni M; Mahdi ES; Basri M; Sattar MA; Noor AM
    Int J Nanomedicine; 2011; 6():387-96. PubMed ID: 21499428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.
    Komatsu T; Sakurada T
    Eur J Pharm Sci; 2012 Dec; 47(5):890-5. PubMed ID: 22985876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects.
    Brunner M; Davies D; Martin W; Leuratti C; Lackner E; Müller M
    Br J Clin Pharmacol; 2011 Jun; 71(6):852-9. PubMed ID: 21241352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of skin permeability for three diclofenac topical formulations: an in vitro study.
    Folzer E; Gonzalez D; Singh R; Derendorf H
    Pharmazie; 2014 Jan; 69(1):27-31. PubMed ID: 24601219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical NSAID formulations.
    McPherson ML; Cimino NM
    Pain Med; 2013 Dec; 14 Suppl 1():S35-9. PubMed ID: 24373109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro delivery of NSAIDs across skin was in proportion to the delivery of essential fatty acids in the vehicle--evidence that solutes permeate skin associated with their solvation cages?
    Heard CM; Gallagher SJ; Harwood J; Maguire PB
    Int J Pharm; 2003 Aug; 261(1-2):165-9. PubMed ID: 12878406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of diclofenac permeation with different formulations: anti-inflammatory study of a selected formula.
    Escribano E; Calpena AC; Queralt J; Obach R; Doménech J
    Eur J Pharm Sci; 2003 Jul; 19(4):203-10. PubMed ID: 12885384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.